Metraipolis › archive › dc_cd88d58c65cc
Safety and efficacy of chidamide for maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with T-ALL/T-LBL — Europe PMC PMID:42103949
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42103949
- DOI
- 10.1007/s00277-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T14:31:53.407Z
- SHA-256 of the archived text
fbcd525c3c781eb6413d0865ced8a250336408e076e410871fd47495ef4d4fb7- Stable URL of this page
https://metraipolis.com/documento/dc_cd88d58c65cc
How to cite
Safety and efficacy of chidamide for maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with T-ALL/T-LBL — Europe PMC PMID:42103949 — Europe PMC (en), https://europepmc.org/article/MED/42103949 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd88d58c65cc (Metraipolis archive dc_cd88d58c65cc, sha256 fbcd525c3c781eb6413d0865ced8a250336408e076e410871fd47495ef4d4fb7)
BibTeX
@misc{dccd88d58c65cc,
title = {Safety and efficacy of chidamide for maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with T-ALL/T-LBL — Europe PMC PMID:42103949},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42103949},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd88d58c65cc; sha256 fbcd525c3c781eb6413d0865ced8a250336408e076e410871fd47495ef4d4fb7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42103949. Agents can read the archived copy with the MCP tool read_document.